Neuland Laboratories EBITDA margin
Was ist das EBITDA margin von Neuland Laboratories?
EBITDA margin von Neuland Laboratories Limited ist 14.85%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Health Care Sektor auf BSE im Vergleich zu Neuland Laboratories
Was macht Neuland Laboratories?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Unternehmen mit ebitda margin ähnlich Neuland Laboratories
- Ferro hat EBITDA margin von 14.83%
- IPL Plastics hat EBITDA margin von 14.83%
- BBX Capital hat EBITDA margin von 14.84%
- Entain PLC hat EBITDA margin von 14.84%
- Rajkumar Forge hat EBITDA margin von 14.84%
- Zix hat EBITDA margin von 14.84%
- Neuland Laboratories hat EBITDA margin von 14.85%
- Ponni Sugars (Erode) hat EBITDA margin von 14.85%
- American Renal Associates hat EBITDA margin von 14.86%
- Accel hat EBITDA margin von 14.86%
- Colfax hat EBITDA margin von 14.86%
- Jyothy Laboratories hat EBITDA margin von 14.87%
- Smiths Plc hat EBITDA margin von 14.87%